Overview

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, parallel group, randomized, double-blind, active controlled, Phase III clinical study of cetirizine injection, 10 mg/mL, compared to diphenhydramine injection, 50 mg/mL (Benadryl or generic equivalent) with acute urticaria requiring treatment.
Phase:
Phase 3
Details
Lead Sponsor:
JDP Therapeutics, Inc.
Treatments:
Diphenhydramine
Promethazine